← Back to Search

Behavioural Intervention

Pinpoint app for Sickle Cell Disease (Pinpoint II Trial)

N/A
Waitlist Available
Led By Valerie Myers, PhD
Research Sponsored by Klein Buendel, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be 13-17 years of age
Be diagnosed with sickle cell disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16-weeks
Awards & highlights

Pinpoint II Trial Summary

This study is evaluating whether an interactive gaming app can help adolescents with sickle cell disease better communicate about their pain.

Eligible Conditions
  • Sickle Cell Disease
  • Sickle Cell Anemia
  • Sickle Cell Thalassemia

Pinpoint II Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Pinpoint II Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sickle Cell Disease (SCD) Knowledge Acquisition
Secondary outcome measures
Adolescent Patient-Provider Interaction Scale
Family Cohesion scale from the Child Health Questionnaire (CHQ)
PROMIS® (Patient-Reported Outcomes Measurement Information System)
+4 more

Pinpoint II Trial Design

1Treatment groups
Experimental Treatment
Group I: Pinpoint AppExperimental Treatment1 Intervention
Tablet and smartphone application.

Find a Location

Who is running the clinical trial?

Klein Buendel, Inc.Lead Sponsor
38 Previous Clinical Trials
19,475 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
375 Previous Clinical Trials
1,214,748 Total Patients Enrolled
Hilton Publishing CompanyUNKNOWN
1 Previous Clinical Trials
13 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Mar 2025